Allegro Ophthalmics, LLC.

Industry

  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
    • Drug Delivery
      • Site Specific
See more in Biomedtracker

Latest on Allegro Ophthalmics, LLC.

Scrip

Asia Deal Watch: Hanmi Licenses Greater China Rights To Dry AMD Injectable To AffaMed

 
• By Ian Haydock, Anju Ghangurde, Dexter Jie Yan, Jung Won Shin, and Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AffaMed, Hanmi Ink License Pact To Deve

Scrip

Deal Watch: Bausch Health Takes Option To Allegro Dry AMD Candidate

 
• By Joseph Haas, Alex Shimmings, and Brian Yang

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bausch Makes $50m Commitment For Risute

Scrip

Pipeline Watch: Phase II Readouts For Pamrevlumab, Mavacamten and Lefitolimod

 
• By John Davis

The progression of investigational products through a series of increasingly more sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for c

Scrip

Venture Funding Deals: Complexa Raises $62m; Evelo, Kezar Bring In $50m Each

 
• By Deanna Kamienski, Beth Allan, Maureen Riordan, and Steven Muntner

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar